Immatics NV (IMTX)
9.16
-0.06
(-0.65%)
USD |
NASDAQ |
Jun 09, 16:00
9.16
0.00 (0.00%)
After-Hours: 20:00
Immatics SG&A Expense (Quarterly) : 16.98M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| MediGene AG | -- |
| InflaRx NV | 3.844M |
| BioNTech SE | 176.43M |
| Twist Bioscience Corp. | 76.08M |
| Prime Medicine, Inc. | 17.40M |